纳米比亚的耐药结核病治疗成功预测因素
Vulika Nangombe1, Mondjila Amkongo2, Brian Godman3,4,5
1Department of Pharmacy Practice and Policy, School of Pharmacy, University of Namibia, Box 13301, Windhoek, Namibia.
JAC-antimicrobial resistance
|May 20, 2025
概括
纳米比亚的耐药结核病 (DR-TB) 治疗成功率有所改善,但仍低于全球目标. 成功的关键预测因素包括年龄较小,女性性别和特定的临床因素,需要针对高风险群体进行有针对性的干预.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 耐药结核病 (DR-TB) 构成了重大的全球卫生挑战,阻碍了到2035年根除该疾病的努力.
- 了解影响DR-TB治疗结果的因素至关重要,特别是在撒哈拉以南非洲等高负担地区,这些数据往往缺乏.
研究的目的:
- 确定纳米比亚DR-TB治疗成功率 (TSR) 的预测因素和模式.
- 为国家结核病计划提供基于证据的建议,以改善DR-TB治疗结果.
主要方法:
- 从2014年到2019年,使用全国DR-TB数据库进行了回顾性观察队列研究.
- 用多变量逻辑回归分析来确定DR-TB患者成功治疗结果的独立预测因素.
主要成果:
- 纳米比亚DR-TB的总体TSR为66.5%,在研究期间观察到的边际增加.
- 与较低治疗成功率相关的因素包括女性,年龄较小 (15岁以下),纳米比亚国籍和双边肺部疾病.
- 相反,基线单抗与更高的治疗成功概率有关.
结论:
- 尽管有所改善,但纳米比亚的DR-TB TSR仍未达到全球目标,并根据患者人口统计和临床表现表现变化.
- 建议针对高风险患者群体 (如女性,年轻人,双边肺结核患者) 的有针对性的干预措施以及基于社区的坚持策略.
- 还应该探索利用临床药剂师的专业知识来提高治疗结果.
相关概念视频
Pulmonary Tuberculosis V
159
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
159
Pulmonary Tuberculosis I
214
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
214
Pulmonary Tuberculosis IV
127
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
127
Pulmonary Tuberculosis III
290
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
290


